A collaboration between clinicians, researchers, and authors in rheumatology, ophthalmology, dermatology, and pulmonology for National Autoimmune Disease Awareness Month in March.
In this interview, Laurent Arnaud, MD, PhD, and Laura Boekel, MD, each discuss findings from their studies on the perspectives and concerns of patients with autoimmune diseases regarding COVID-19 vaccination.
For patients with advanced melanoma, response to immune checkpoint inhibitors is similar for those with and without preexisting autoimmune disease.
This study compared survival outcomes in patients with lung cancer with and without an existing autoimmune disorder.
Autoimmune disease comorbidity among adults with atopic dermatitis is common.
Researchers quantified the risk for death among patients with rare autoimmune rheumatic diseases vs the general population during the COVID-19 pandemic.
Study authors reviewed the evidence on the effectiveness of low-dose aspirin in the primary prevention of cardiovascular disease in systemic autoimmune rheumatic diseases.
Researchers described patients with autoimmune inflammatory rheumatic diseases with COVID-19 and the risk factors associated with hospitalization related to COVID-19.
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
Researchers evaluated the prevalence of hospital-diagnosed COVID-19 in chronic inflammatory and autoimmune rheumatic diseases.
